In September, the Trump administration took what it called "bold actions" on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, commissioner of the Food and Drug Administration, claimed a " growing body of evidence suggests" the drug could be helpful. And at a White House press event, Makary suggested it might help " 20, 40, 50 percent of kids with autism ."

" Hundreds of thousands of kids , in my opinion, will benefit," he said at another point in the event.

The bold claims were apparently persuasive. A study published in The Lancet last week found that new outpatient prescriptions of leucovorin for children ages 5 to 17 shot up 71 percent in the three months after the Trump administration's actions.

Read full article

Comments

In September, the Trump administration took what it called "bold actions" on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, commissioner of the Food and Drug Administration, claimed a " growing body of evidence suggests" the drug could be helpful. And at a White House press event, Makary suggested it might help " 20, 40, 50 percent of kids with autism ."

" Hundreds of thousands of kids , in my opinion, will benefit," he said at another point in the event.

The bold claims were apparently persuasive. A study published in The Lancet last week found that new outpatient prescriptions of leucovorin for children ages 5 to 17 shot up 71 percent in the three months after the Trump administration's actions.

Read full article

Comments

In September, the Trump administration took what it called "bold actions" on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, commissioner of the Food and Drug Administration, claimed a " growing body of evidence suggests" the drug could be helpful. And at a White House press event, Makary suggested it might help " 20, 40, 50 percent of kids with autism ."

" Hundreds of thousands of kids , in my opinion, will benefit," he said at another point in the event.

The bold claims were apparently persuasive. A study published in The Lancet last week found that new outpatient prescriptions of leucovorin for children ages 5 to 17 shot up 71 percent in the three months after the Trump administration's actions.

Read full article

Comments

Computer engineers and programmers have long relied on reverse engineering as a way to copy the functionality of a computer program without copying that program's copyright-protected code directly. Now, AI coding tools are raising new issues with how that "clean room" rewrite process plays out both legally, ethically, and practically.

Those issues came to the forefront last week with the release of a new version of chardet , a popular open source python library for automatically detecting character encoding. The repository was originally written by coder Mark Pilgrim in 2006 and released under an LGPL license that placed strict limits on how it could be reused and redistributed.

Dan Blanchard took over maintenance of the repository in 2012 but waded into some controversy with the release of version 7.0 of chardet last week. Blanchard described that overhaul as "a ground-up, MIT-licensed rewrite" of the entire library built with the help of Claude Code to be "much faster and more accurate" than what came before.

Read full article

Comments

Computer engineers and programmers have long relied on reverse engineering as a way to copy the functionality of a computer program without copying that program's copyright-protected code directly. Now, AI coding tools are raising new issues with how that "clean room" rewrite process plays out both legally, ethically, and practically.

Those issues came to the forefront last week with the release of a new version of chardet , a popular open source python library for automatically detecting character encoding. The repository was originally written by coder Mark Pilgrim in 2006 and released under an LGPL license that placed strict limits on how it could be reused and redistributed.

Dan Blanchard took over maintenance of the repository in 2012 but waded into some controversy with the release of version 7.0 of chardet last week. Blanchard described that overhaul as "a ground-up, MIT-licensed rewrite" of the entire library built with the help of Claude Code to be "much faster and more accurate" than what came before.

Read full article

Comments

Computer engineers and programmers have long relied on reverse engineering as a way to copy the functionality of a computer program without copying that program's copyright-protected code directly. Now, AI coding tools are raising new issues with how that "clean room" rewrite process plays out both legally, ethically, and practically.

Those issues came to the forefront last week with the release of a new version of chardet , a popular open source python library for automatically detecting character encoding. The repository was originally written by coder Mark Pilgrim in 2006 and released under an LGPL license that placed strict limits on how it could be reused and redistributed.

Dan Blanchard took over maintenance of the repository in 2012 but waded into some controversy with the release of version 7.0 of chardet last week. Blanchard described that overhaul as "a ground-up, MIT-licensed rewrite" of the entire library built with the help of Claude Code to be "much faster and more accurate" than what came before.

Read full article

Comments

Meta has acquired Moltbook, the Reddit-esque simulated social network made up of AI agents that went viral a few weeks ago. The company will hire Moltbook creator Matt Schlicht and his business partner, Ben Parr, to work within Meta Superintelligence Labs.

The terms of the deal have not been disclosed.

As for what interested Meta about the work done on Moltbook, there is a clue in the statement issued to press by a Meta spokesperson, who flagged the Moltbook founders' "approach to connecting agents through an always-on directory," saying it "is a novel step in a rapidly developing space." They added, "We look forward to working together to bring innovative, secure agentic experiences to everyone."

Read full article

Comments

Meta has acquired Moltbook, the Reddit-esque simulated social network made up of AI agents that went viral a few weeks ago. The company will hire Moltbook creator Matt Schlicht and his business partner, Ben Parr, to work within Meta Superintelligence Labs.

The terms of the deal have not been disclosed.

As for what interested Meta about the work done on Moltbook, there is a clue in the statement issued to press by a Meta spokesperson, who flagged the Moltbook founders' "approach to connecting agents through an always-on directory," saying it "is a novel step in a rapidly developing space." They added, "We look forward to working together to bring innovative, secure agentic experiences to everyone."

Read full article

Comments

Meta has acquired Moltbook, the Reddit-esque simulated social network made up of AI agents that went viral a few weeks ago. The company will hire Moltbook creator Matt Schlicht and his business partner, Ben Parr, to work within Meta Superintelligence Labs.

The terms of the deal have not been disclosed.

As for what interested Meta about the work done on Moltbook, there is a clue in the statement issued to press by a Meta spokesperson, who flagged the Moltbook founders' "approach to connecting agents through an always-on directory," saying it "is a novel step in a rapidly developing space." They added, "We look forward to working together to bring innovative, secure agentic experiences to everyone."

Read full article

Comments